ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 294

Physical Activity In Children With Juvenile Idiopathic Arthritis (JIA): The LEAP (Linking Exercise, Activity and Pathophysiology in Childhood Arthritis) Study

Lori B. Tucker1, Heather A. McKay2, Leanne M. Ward3, Jaime Guzman1, Adam Baxter-Jones4, Kiem Oen5, Alan M. Rosenberg6, Johannes Roth3, Elizabeth Stringer7, Rae SM Yeung8, Kristin M. Houghton9, Heather Macdonald10, Debbie Ehrmann Feldman11, Ciaran M. Duffy12 and LEAP Study Investigators13, 1Rheumatology, BC Children's Hospital and University of British Columbia, Vancouver, BC, Canada, 2Family Practice and Orthoepedics, University of British Columbia, Vancouver, BC, Canada, 3University of Ottawa, Ottawa, ON, Canada, 4College of Kinesiology, University of Saskatchewan, Saskatoon, SK, Canada, 5University of Manitoba, Winnipeg, MB, Canada, 6Department of Pediatrics, University of Saskatchewan, Saskatoon, SK, Canada, 7Department of Rheumatology, IWK Health Centre, Halifax, NS, Canada, 8Rheumatology, The Hospital for Sick Children and University of Toronto, Toronto, ON, Canada, 9University of British Columbia, Vancouver, BC, Canada, 10The University of British Columbia, Vancouver, BC, Canada, 11Rehabilitation, Université de Montréal, Montreal, QC, Canada, 12Rheumatology, Children's Hospital of Eastern Ontario and University of Ottawa, Ottawa, ON, Canada, 13BC Children's Hospital, Vancouver, BC, Canada

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Juvenile Arthritis, pediatric rheumatology and physical activity

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Pediatric Rheumatology - Clinical and Therapeutic Aspects I: Juvenile Idiopathic Arthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose:   Although children with JIA have lower fitness levels than healthy peers, little is known about their level of habitual physical activity.   The LEAP study is a prospective longitudinal multicentre study of children and teens with JIA, aimed at describing the trajectory of physical activity (PA) in JIA, and its relationship to disease factors, inflammation, quality of life, bone health and muscle function.  Here we report PA levels of children and teens with JIA in early and late disease at study entry.

Methods: We enrolled patients with JIA (aged 8-16 y) at 12 pediatric rheumatology centres in Canada as either an inception cohort (early disease; within 6 months of diagnosis) or an established disease cohort (late disease; > 2yr after diagnosis).  We assessed PA with a validated Physical Activity Questionnaire for children (PAQ-C, age 8-13 y) or teens (PAQ-A, age 14-16 y).  This 7-day recall self-report tool has scores from 0 (no PA) to 5, high level ofPA.  Participants record weekly PA across a wide range of activities and sports; normative data has been published.   Patients completed a pain scale (VAS 0-100), the Childhood Health Assessment Questionnaire (CHAQ), and Juvenile Arthritis Quality of life Questionnaire (JAQQ). Examining physicians recorded physician global assessment of disease activity (VAS 0-100) and presence of active joints.   We used descriptive statistics and two-way ANOVA to assess differences between groups.  We used PAQ standard population normative values to compare to JIA patients (female 2.69, SD 0.62; male 3.0 SD 0.72). 

Results: We collected complete PA data from 127 patients (85 F, 42 M, med age 9.5 y) from March 2012-April 2013.  The early cohort included 49 patients (enrolled median 1.2 mo after diagnosis) and the late cohort included 78 patients (enrolled median 3.3 yr after diagnosis).    Active arthritis was found in 48 patients, with a mean of 5.4 active joints (range 1-56);  PGA was a mean of 12.7 (range 0-74).  Overall mean PAQ score for the JIA patients was 2.6 (SD 0.73, range 1-4).Table 1 describes PAQ scores by sex, disease cohort, and presence of active arthritis.  When controlled for sex, PAQ scores were significantly different between new onset and late disease.   Factors significantly associated with PAQ score included patient-reported pain (p=0.001), CHAQ score (p<0.0001), JAQQ score (p=0.0001), number of active joints (p=0.002) and PGA (p=0.001); ESR and presence of joints with limited range of motion were not associated with PAQ score. 

Table  1.    PAQ scores in patients with JIA

 

Total

Female (mean.SD)

Female z-score (mean, SD)

Male

(mean, SD)

Male z-score (mean, SD)

Total

2.5 (O.73)

2.4 (0.66)

-0.46 (1.08)

2.71 (0.822)

-0.39(1.14)

Early disease

2.34(0.73)

2.31(0.67)

-0.60(1.08)

2.38(0.85)

-0.85(1.18)

Late disease

2.60(0.71)

2.45(0.66)

-0.38(1.07)

2.96(0.72)

-0.05(1.0)

Active joints present

2.27(0.68)

2.12(0.6)

-0.92 (0.97)

2.56(0.76)

-0.61(1.06)

No active joints

2.68(0.71)

2.62(0.63)

-0.10(1.01)

2.81(0.86)

-0.44(1.14)

Conclusion:   Children with JIA reported significantly lower levels of PA than healthy peers; this was especially evident in girls, patients with active arthritis, and early in disease.  Disease activity, self reported quality of life and functional status may play a role in moderating PA in JIA.  The longitudinal data collection of the LEAP study will provide important insight into factors associated with poor PA in JIA.


Disclosure:

L. B. Tucker,
None;

H. A. McKay,
None;

L. M. Ward,
None;

J. Guzman,
None;

A. Baxter-Jones,
None;

K. Oen,
None;

A. M. Rosenberg,
None;

J. Roth,
None;

E. Stringer,
None;

R. S. Yeung,
None;

K. M. Houghton,
None;

H. Macdonald,
None;

D. E. Feldman,
None;

C. M. Duffy,
None;

L. S. Investigators,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/physical-activity-in-children-with-juvenile-idiopathic-arthritis-jia-the-leap-linking-exercise-activity-and-pathophysiology-in-childhood-arthritis-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology